Literature DB >> 9751502

Alternative splicing of the D2 dopamine receptor messenger ribonucleic acid is modulated by activated sex steroid receptors in the MMQ prolactin cell line.

D Guivarc'h1, J D Vincent, P Vernier.   

Abstract

The two isoforms of the D2 dopamine receptor are generated by alternative splicing of the exon 6 of the premessenger RNA (pre-mRNA), changing the length of the third cytoplasmic loop involved in the coupling to G proteins. In the MMQ PRL cell line, sex steroid hormones modulated the proportion of the two D2 receptor isoforms. Under controlled culture conditions, 17beta-estradiol (E2) strongly favored the production of the long isoform of D2 mRNA over the short one, whereas both isoforms were equally abundant when culture medium was hormone depleted. In the presence of progesterone (P), E2 action was inhibited, and equal amounts of each D2 receptor isoform were produced in the cells. Hormone treatments never modified either the total amount of D2 receptor mRNA and D2 receptor binding sites or D2 receptor-mediated inhibition of adenylyl cyclase. Specific antagonists demonstrated that the activity of each hormone depended on their nuclear receptors. Inhibitors of gene transcription or translation also showed that their activity required protein synthesis. The expression of the short D2 receptor isoform was never prominent, even at the single cell level. Analysis of the intron sequence flanking alternative exon 6 showed that only the upstream intron presented two sequence tracts known to be targets for splicing factors. Taken together, these results provide converging evidence for a physiologically relevant mechanism by which sex steroid receptors could regulate the expression of a splicing factor favoring the production of the long dopamine D2 receptor isoform.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9751502     DOI: 10.1210/endo.139.10.6246

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  19 in total

1.  Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2).

Authors:  Y Hofmann; C L Lorson; S Stamm; E J Androphy; B Wirth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

Review 2.  Dopamine receptors for every species: gene duplications and functional diversification in Craniates.

Authors:  Stéphane Le Crom; Marika Kapsimali; Pierre-Olivier Barôme; Philippe Vernier
Journal:  J Struct Funct Genomics       Date:  2003

3.  Dopamine, dopamine D2 receptor short isoform, transforming growth factor (TGF)-beta1, and TGF-beta type II receptor interact to inhibit the growth of pituitary lactotropes.

Authors:  D K Sarkar; K Chaturvedi; S Oomizu; N I Boyadjieva; C P Chen
Journal:  Endocrinology       Date:  2005-06-16       Impact factor: 4.736

Review 4.  Alternative splicing of G protein-coupled receptors: physiology and pathophysiology.

Authors:  Danijela Markovic; R A John Challiss
Journal:  Cell Mol Life Sci       Date:  2009-07-23       Impact factor: 9.261

Review 5.  Genesis of prolactinomas: studies using estrogen-treated animals.

Authors:  Dipak K Sarkar
Journal:  Front Horm Res       Date:  2006       Impact factor: 2.606

6.  Regulatory roles of heterogeneous nuclear ribonucleoprotein M and Nova-1 protein in alternative splicing of dopamine D2 receptor pre-mRNA.

Authors:  Eonyoung Park; Ciro Iaccarino; Jiwon Lee; Ilmin Kwon; Sun Mi Baik; Myungjin Kim; Jae Young Seong; Gi Hoon Son; Emiliana Borrelli; Kyungjin Kim
Journal:  J Biol Chem       Date:  2011-05-26       Impact factor: 5.157

7.  The number of cells expressing dopamine D2 receptor mRNA in rat brain caudate putamen is higher in oestrus.

Authors:  Matjaz Ursic; Srdan V Bavdek; Jelka Zabavnik
Journal:  J Anat       Date:  2003-05       Impact factor: 2.610

8.  Expression analysis of dopamine receptor subtypes in normal human pituitaries, nonfunctioning pituitary adenomas and somatotropinomas, and the association between dopamine and somatostatin receptors with clinical response to octreotide-LAR in acromegaly.

Authors:  Leonardo Vieira Neto; Evelyn de O Machado; Raul M Luque; Giselle F Taboada; Jorge B Marcondes; Leila M C Chimelli; Leonardo Pereira Quintella; Paulo Niemeyer; Denise P de Carvalho; Rhonda D Kineman; Mônica R Gadelha
Journal:  J Clin Endocrinol Metab       Date:  2009-03-17       Impact factor: 5.958

9.  Ethanol alters production and secretion of estrogen-regulated growth factors that control prolactin-secreting tumors in the pituitary.

Authors:  Dipak K Sarkar; Nadka I Boyadjieva
Journal:  Alcohol Clin Exp Res       Date:  2007-12       Impact factor: 3.455

10.  Alteration in G proteins and prolactin levels in pituitary after ethanol and estrogen treatment.

Authors:  Kirti Chaturvedi; Dipak K Sarkar
Journal:  Alcohol Clin Exp Res       Date:  2008-03-11       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.